The Process Solutions division of Merck India has announced its 3rd Annual Pharma Forum in Hyderabad on 10th August, 2022, a statement from the company said.
It also said that the focus of the event is “Shaping the next-generation processing of pharma manufacturing.” The forum creates a platform for deep dive discussions with the industry experts on the future of the biopharma manufacturing, providing the latest insights on the process trends and quality approach in aseptic processing and discuss the regulations around it.
Industry experts like Dr Ranjit Barshikar, CEO, QbD International, QbD/cGMP Consulting, United Nations Adviser, Geneva; Somasundaram G, Senior Consultant, Asia Pacific, Process Solutions, Merck KGaA; and Ramesh Raju, Head of Operations, Validation Services Lab, Merck KGaA, amongst others, said the statement.
These experts will share their views from their respective areas of expertise, followed by a panel discussion on the most discussed topics in sterile pharma manufacturing, mentioned the statement.
Merck India has been creating various platforms for the biopharma industry in India to discuss the latest trends by bringing together eminent leaders from the industry and the subject matter experts across the globe, the statement concluded.